Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin or Linagliptin vs Metformin in PCOS
NCT05200793Phase 4Unknown
- Sponsor
- Alexandria University
- Start
- Dec 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of empagliflozin and linagliptin in polycystic ovary syndrome (PCOS) (3 arms), sponsored by Alexandria University. Primary endpoints: Fertility parameters, Follicle-stimulating hormone and 3 more. Status: unknown.
02
Drugs
empagliflozinlinagliptin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT05200793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05200793.